122 related articles for article (PubMed ID: 30396283)
1. Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411.
Sharma VR; Thomas SD; Miller DM; Rezzoug F
Cancer Invest; 2018; 36(9-10):475-491. PubMed ID: 30396283
[TBL] [Abstract][Full Text] [Related]
2. AS1411 binds to nucleolin via its parallel structure and disrupts the exos-miRNA-27a-mediated reciprocal activation loop between glioma and astrocytes.
Sun X; Zhang W; Gou C; Wang X; Wang X; Shao X; Chen X; Chen Z
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167211. PubMed ID: 38701957
[TBL] [Abstract][Full Text] [Related]
3. Direct investigations of interactions between nucleolins and aptamers on pancreatic cancer and normal cells by atomic force microscopy.
Li X; Chen L; Kong S; Zhong H; Jiang F; Zhao W
Ultramicroscopy; 2024 Sep; 263():113986. PubMed ID: 38762964
[TBL] [Abstract][Full Text] [Related]
4. Nucleolin-targeted Extracellular Vesicles as a Versatile Platform for Biologics Delivery to Breast Cancer.
Wang Y; Chen X; Tian B; Liu J; Yang L; Zeng L; Chen T; Hong A; Wang X
Theranostics; 2017; 7(5):1360-1372. PubMed ID: 28435471
[TBL] [Abstract][Full Text] [Related]
5. Anti-nucleolin aptamer AS1411: an advancing therapeutic.
Van den Avont A; Sharma-Walia N
Front Mol Biosci; 2023; 10():1217769. PubMed ID: 37808518
[TBL] [Abstract][Full Text] [Related]
6. Study of the Function of G-Rich Aptamers Selected for Lung Adenocarcinoma.
Hu J; Zhao Z; Liu Q; Ye M; Hu B; Wang J; Tan W
Chem Asian J; 2015 Jul; 10(7):1519-25. PubMed ID: 25864879
[TBL] [Abstract][Full Text] [Related]
7. Grafting aptamers onto gold nanostars increases in vitro efficacy in a wide range of cancer cell types.
Dam DH; Culver KS; Odom TW
Mol Pharm; 2014 Feb; 11(2):580-7. PubMed ID: 24422969
[TBL] [Abstract][Full Text] [Related]
8. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.
Bates PJ; Laber DA; Miller DM; Thomas SD; Trent JO
Exp Mol Pathol; 2009 Jun; 86(3):151-64. PubMed ID: 19454272
[TBL] [Abstract][Full Text] [Related]
9. Nucleolin/C23 is a negative regulator of hydrogen peroxide-induced apoptosis in HUVECs.
Zhang B; Wang H; Jiang B; Liang P; Liu M; Deng G; Xiao X
Cell Stress Chaperones; 2010 May; 15(3):249-57. PubMed ID: 19757191
[TBL] [Abstract][Full Text] [Related]
10. Preliminary study on the effect of nucleolin specific aptamer-miRNA let-7d chimera on Janus kinase-2 expression level and activity in gastric cancer (MKN-45) cells.
Ramezanpour M; Daei P; Tabarzad M; Khanaki K; Elmi A; Barati M
Mol Biol Rep; 2019 Feb; 46(1):207-215. PubMed ID: 30415442
[TBL] [Abstract][Full Text] [Related]
11. Delivery of thymoquinone to cancer cells with as1411-conjugated nanodroplets.
Murphy EM; Centner CS; Bates PJ; Malik MT; Kopechek JA
PLoS One; 2020; 15(5):e0233466. PubMed ID: 32437399
[TBL] [Abstract][Full Text] [Related]
12. AS1411-functionalized delivery nanosystems for targeted cancer therapy.
Kozani PS; Kozani PS; Malik MT
Explor Med; 2021; 2():146-166. PubMed ID: 34723284
[TBL] [Abstract][Full Text] [Related]
13. Insights on the molecular mechanisms of cytotoxicity induced by AS1411 linked to folate-functionalized DNA nanocages in cancer cells.
Unida V; Mangano E; Camboni T; Consolandi C; Desideri A; Severgnini M; Cifola I; Biocca S
Nanomedicine; 2023 Nov; 54():102710. PubMed ID: 37734452
[TBL] [Abstract][Full Text] [Related]
14. "Light-On" Fluorescent Nanoprobes for Monitoring Dynamic Distribution of Cellular Nucleolin During Pyroptosis.
Kong J; Ju X; Qi G; Wang J; Diao X; Wang B; Zhang C; Li J; Jin Y
Anal Chem; 2024 Jan; 96(2):926-933. PubMed ID: 38158373
[TBL] [Abstract][Full Text] [Related]
15. Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia.
Chen Y; Wu Z; Wang L; Lin M; Jiang P; Wen J; Li J; Hong Y; Zheng X; Yang X; Zheng J; Gale RP; Yang T; Hu J
Cell Oncol (Dordr); 2023 Dec; 46(6):1709-1724. PubMed ID: 37486460
[TBL] [Abstract][Full Text] [Related]
16. Pre-B acute lymphoblastic leukemia expresses cell surface nucleolin as a 9-O-acetylated sialoglycoprotein.
Joo EJ; Wasik BR; Parrish C; Paz H; Mϋhlenhoff M; Abdel-Azim H; Groffen J; Heisterkamp N
Sci Rep; 2018 Nov; 8(1):17174. PubMed ID: 30464179
[TBL] [Abstract][Full Text] [Related]
17. Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review).
Thongchot S; Aksonnam K; Thuwajit P; Yenchitsomanus PT; Thuwajit C
Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37477132
[TBL] [Abstract][Full Text] [Related]
18. DNA Walker-Regulated Cancer Cell Growth Inhibition.
Li F; Cha TG; Pan J; Ozcelikkale A; Han B; Choi JH
Chembiochem; 2016 Jun; 17(12):1138-41. PubMed ID: 27059426
[TBL] [Abstract][Full Text] [Related]
19. On-Site-Activated Transmembrane Logic DNA Nanodevice Enables Highly Specific Imaging of Cancer Cells by Targeting Tumor-Related Nucleolin and Intracellular MicroRNA.
Huang X; Chen M; Huang Z; Zhang Y; Shen T; Shi Y; Tong Y; Zou X; Liu SY; Guo J; Dai Z
Anal Chem; 2023 Oct; 95(39):14746-14753. PubMed ID: 37723832
[TBL] [Abstract][Full Text] [Related]
20. DNA Nanoribbon for Efficient Anti-miRNA Peptide Nucleic Acid Delivery and Synergistic Enhancement of Cancer Cell Apoptosis.
Fu P; Chen H; Ouyang L; Li L; Wang Y; Qian S; Cao Z; Wu K; Chao J; Zheng J
Anal Chem; 2022 Dec; ():. PubMed ID: 36542541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
